[144] ARGAN INC SEC Filing

Rhea-AI Filing Summary

Form 144 filing for ARGAN INC (AGX) discloses a proposed sale of 15,000 common shares on the NYSE through Merrill Lynch with an aggregate market value of $4,186,350 and approximately 13,811,575 shares outstanding. The filing lists the acquisition of 32,206 shares on 06/11/2025 via a stock option from Cynthia A Flanders, with the acquisition settled on 06/11/2025 on a cashless basis. The intended approximate sale date is 10/02/2025.

The filing lacks the name of the person on whose account the securities will be sold and does not provide a filing date in the remarks section. It also states there were no securities sold in the past three months by the person for whose account the sale is reported.

Positive

• Planned sale fully disclosed: class, broker, number of shares, aggregate market value, exchange, and approximate sale date are provided
• Acquisition details provided: date (06/11/2025), method (stock option), counterparty (Cynthia A Flanders), and payment method (cashless) are reported
• No sales in prior 3 months: the filer reports nothing to report for sales in the past 90 days

Negative

• Missing seller identity: the form does not name the person for whose account the securities are to be sold
• Missing notice date: the Date of Notice field is blank in the remarks section, reducing traceability
• Large aggregate value disclosed without context: $4,186,350 market value is reported but issuer financial context is not provided in this filing

Insights

Securities Analyst

TL;DR: Routine insider resale notice: a 15,000-share planned sale, sourced from a recent cashless option exercise.

The filing documents a standard Rule 144 notice for AGX showing a proposed public sale of 15,000 common shares with an aggregate market value of $4,186,350, to occur on or about 10/02/2025 on the NYSE. The shares were acquired 06/11/2025 via a stock option and settled cashless the same day. No prior sales in the past three months are reported, which may be relevant for volume-aggregation and compliance with Rule 144 thresholds. The disclosure is transactional and does not include issuer financials or forward-looking statements.

Compliance / Risk Analyst

TL;DR: Disclosure appears routine but is incomplete: key filer identity and notice date are missing.

The form meets core Rule 144 elements by identifying class, broker, shares, acquisition method, and planned sale date. However, the absence of the name of the person on whose account the securities are to be sold and the missing notice date reduce the filing's completeness for third-party review and investor transparency. The representation about no undisclosed material adverse information is included as required.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	MERRILL LYNCH 11810 GRAND PARK AVE STE 800 N.BETHESDA MD 20852	15000	4186350	13811575	10/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	06/11/2025	TOCK OPTION	CYNTHIA A FLANDERS			32206	06/11/2025	CASHLESS

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for ARGAN INC (AGX) announce?

The form notifies a proposed sale of 15,000 common shares on the NYSE with aggregate market value of $4,186,350 and an approximate sale date of 10/02/2025.

How were the shares being sold acquired according to the filing?

The filing states 32,206 shares were acquired on 06/11/2025 via a stock option from Cynthia A Flanders, settled on 06/11/2025 on a cashless basis.

Does the filing report any securities sold in the past three months for AGX?

No. The filing explicitly shows Nothing to Report for securities sold during the past three months by the person for whose account the sale is reported.

Which broker is handling the proposed sale in the Form 144?

The broker named is Merrill Lynch at the address provided, which will execute the sale on the NYSE.

Are there any missing details in this Form 144 that investors should note?

Yes. The filing does not provide the name of the person for whose account the securities will be sold and omits the date of notice in the remarks section.